Moleculin Biotech, Inc. — Form D

Moleculin Biotech, Inc. of HOUSTON, TX, a company, filed a Form D exempt-offering notice with the SEC on 2016-05-16. The offering totals $6.0M, of which $6.0M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2016-05-16
• Form: D
• Accession: 0001659617-16-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $6.0M
• Amount sold: $6.0M
• Investors: 129
• Date of first sale: 2016-05-02
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-263286

Issuer

• Name: Moleculin Biotech, Inc.
• CIK: 0001659617
• Entity type: Corporation
• Jurisdiction: DELAWARE
• Incorporated: 2015
• Address: 2575 WEST BELLFORT, HOUSTON, TX, 77054
• Phone: 713-300-5160

Officers, directors & promoters (3)

More

• CIK 1659617 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search